HEADER HYDROLASE/HYDROLASE INHIBITOR 23-JAN-12 4DFG TITLE CRYSTAL STRUCTURE OF WILD-TYPE HIV-1 PROTEASE WITH TITLE 2 CYCLOPENTYLTETRAHYDRO- FURANYL URETHANES AS P2-LIGAND, GRL-0249A COMPND MOL_ID: 1; COMPND 2 MOLECULE: PROTEASE; COMPND 3 CHAIN: A, B; COMPND 4 FRAGMENT: RESIDUES 500-598; COMPND 5 EC: 3.4.23.16; COMPND 6 ENGINEERED: YES; COMPND 7 MUTATION: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HUMAN IMMUNODEFICIENCY VIRUS TYPE 1; SOURCE 3 ORGANISM_COMMON: HIV-1; SOURCE 4 ORGANISM_TAXID: 11686; SOURCE 5 GENE: GAG-POL; SOURCE 6 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 7 EXPRESSION_SYSTEM_TAXID: 562; SOURCE 8 EXPRESSION_SYSTEM_STRAIN: BL21 (DE3); SOURCE 9 EXPRESSION_SYSTEM_VECTOR_TYPE: PLASMID; SOURCE 10 EXPRESSION_SYSTEM_PLASMID: PET11A KEYWDS ASPARTIC ACID PROTEASE, HIV-1 PROTEASE INHIBITOR GRL-0249A, KEYWDS 2 CYCLOPENTYLTETRAHYDRO- FURANYL URETHANES P2-LIGANDS, WILD-TYPE HIV-1 KEYWDS 3 PROTEASE, HYDROLASE-HYDROLASE INHIBITOR COMPLEX EXPDTA X-RAY DIFFRACTION AUTHOR Y.-F.WANG,J.AGNISWAMY,I.T.WEBER REVDAT 2 13-SEP-23 4DFG 1 REMARK SEQADV LINK REVDAT 1 21-MAR-12 4DFG 0 JRNL AUTH A.K.GHOSH,B.D.CHAPSAL,M.STEFFEY,J.AGNISWAMY,Y.F.WANG, JRNL AUTH 2 M.AMANO,I.T.WEBER,H.MITSUYA JRNL TITL SUBSTITUENT EFFECTS ON P2-CYCLOPENTYLTETRAHYDROFURANYL JRNL TITL 2 URETHANES: DESIGN, SYNTHESIS, AND X-RAY STUDIES OF POTENT JRNL TITL 3 HIV-1 PROTEASE INHIBITORS. JRNL REF BIOORG.MED.CHEM.LETT. V. 22 2308 2012 JRNL REFN ISSN 0960-894X JRNL PMID 22364812 JRNL DOI 10.1016/J.BMCL.2012.01.061 REMARK 2 REMARK 2 RESOLUTION. 1.23 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : SHELXL-97 REMARK 3 AUTHORS : G.M.SHELDRICK REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 1.23 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 10.00 REMARK 3 DATA CUTOFF (SIGMA(F)) : 0.000 REMARK 3 COMPLETENESS FOR RANGE (%) : 91.2 REMARK 3 CROSS-VALIDATION METHOD : FREE R REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT (NO CUTOFF). REMARK 3 R VALUE (WORKING + TEST SET, NO CUTOFF) : 0.146 REMARK 3 R VALUE (WORKING SET, NO CUTOFF) : 0.144 REMARK 3 FREE R VALUE (NO CUTOFF) : 0.180 REMARK 3 FREE R VALUE TEST SET SIZE (%, NO CUTOFF) : 5.000 REMARK 3 FREE R VALUE TEST SET COUNT (NO CUTOFF) : 3104 REMARK 3 TOTAL NUMBER OF REFLECTIONS (NO CUTOFF) : 62014 REMARK 3 REMARK 3 FIT/AGREEMENT OF MODEL FOR DATA WITH F>4SIG(F). REMARK 3 R VALUE (WORKING + TEST SET, F>4SIG(F)) : 0.132 REMARK 3 R VALUE (WORKING SET, F>4SIG(F)) : 0.130 REMARK 3 FREE R VALUE (F>4SIG(F)) : 0.167 REMARK 3 FREE R VALUE TEST SET SIZE (%, F>4SIG(F)) : 5.000 REMARK 3 FREE R VALUE TEST SET COUNT (F>4SIG(F)) : 2553 REMARK 3 TOTAL NUMBER OF REFLECTIONS (F>4SIG(F)) : 50823 REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 1512 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 50 REMARK 3 SOLVENT ATOMS : 228 REMARK 3 REMARK 3 MODEL REFINEMENT. REMARK 3 OCCUPANCY SUM OF NON-HYDROGEN ATOMS : 1729.3 REMARK 3 OCCUPANCY SUM OF HYDROGEN ATOMS : 1641.0 REMARK 3 NUMBER OF DISCRETELY DISORDERED RESIDUES : 39 REMARK 3 NUMBER OF LEAST-SQUARES PARAMETERS : 18693 REMARK 3 NUMBER OF RESTRAINTS : 26820 REMARK 3 REMARK 3 RMS DEVIATIONS FROM RESTRAINT TARGET VALUES. REMARK 3 BOND LENGTHS (A) : 0.013 REMARK 3 ANGLE DISTANCES (A) : 0.033 REMARK 3 SIMILAR DISTANCES (NO TARGET VALUES) (A) : 0.000 REMARK 3 DISTANCES FROM RESTRAINT PLANES (A) : 0.029 REMARK 3 ZERO CHIRAL VOLUMES (A**3) : 0.073 REMARK 3 NON-ZERO CHIRAL VOLUMES (A**3) : 0.075 REMARK 3 ANTI-BUMPING DISTANCE RESTRAINTS (A) : 0.027 REMARK 3 RIGID-BOND ADP COMPONENTS (A**2) : 0.004 REMARK 3 SIMILAR ADP COMPONENTS (A**2) : 0.052 REMARK 3 APPROXIMATELY ISOTROPIC ADPS (A**2) : 0.082 REMARK 3 REMARK 3 BULK SOLVENT MODELING. REMARK 3 METHOD USED: NULL REMARK 3 REMARK 3 STEREOCHEMISTRY TARGET VALUES : ENGH AND HUBER REMARK 3 SPECIAL CASE: NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: CONJUGAGE GRADIENT MINIMIZATION REMARK 4 REMARK 4 4DFG COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 27-JAN-12. REMARK 100 THE DEPOSITION ID IS D_1000070262. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 18-NOV-09 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : 4.8 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : APS REMARK 200 BEAMLINE : 22-ID REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 0.8 REMARK 200 MONOCHROMATOR : SI 220 CHANNEL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : IMAGE PLATE REMARK 200 DETECTOR MANUFACTURER : MAR SCANNER 300 MM PLATE REMARK 200 INTENSITY-INTEGRATION SOFTWARE : HKL-2000 REMARK 200 DATA SCALING SOFTWARE : HKL-2000 REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 62205 REMARK 200 RESOLUTION RANGE HIGH (A) : 1.230 REMARK 200 RESOLUTION RANGE LOW (A) : 50.000 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : 0.000 REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 91.3 REMARK 200 DATA REDUNDANCY : 5.100 REMARK 200 R MERGE (I) : 0.09600 REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : 13.8000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 1.23 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 1.27 REMARK 200 COMPLETENESS FOR SHELL (%) : 54.7 REMARK 200 DATA REDUNDANCY IN SHELL : 1.70 REMARK 200 R MERGE FOR SHELL (I) : 0.38900 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : 2.000 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: PHASES REMARK 200 STARTING MODEL: 2QCI REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 54.35 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.69 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: THE PROTEIN CONCENTRATION WAS ABOUT 4 REMARK 280 MG/ML; 1.2 M NACL AND 0.1 M ACETATE BUFFER PH 4.8, RATIO PROTEIN: REMARK 280 INHIBITOR 1:5 AND 30% GLYCEROL FOR CYRO PROTECTION. VAPOR REMARK 280 DIFFUSION, HANGING DROP, TEMPERATURE 298K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 21 21 2 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X,-Y,Z REMARK 290 3555 -X+1/2,Y+1/2,-Z REMARK 290 4555 X+1/2,-Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 2 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 3 -1.000000 0.000000 0.000000 29.29000 REMARK 290 SMTRY2 3 0.000000 1.000000 0.000000 42.96500 REMARK 290 SMTRY3 3 0.000000 0.000000 -1.000000 0.00000 REMARK 290 SMTRY1 4 1.000000 0.000000 0.000000 29.29000 REMARK 290 SMTRY2 4 0.000000 -1.000000 0.000000 42.96500 REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: DIMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: DIMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 TOTAL BURIED SURFACE AREA: 4860 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 9500 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: -77.0 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: A, B REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: COVALENT BOND ANGLES REMARK 500 REMARK 500 THE STEREOCHEMICAL PARAMETERS OF THE FOLLOWING RESIDUES REMARK 500 HAVE VALUES WHICH DEVIATE FROM EXPECTED VALUES BY MORE REMARK 500 THAN 6*RMSD (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 500 IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT: (10X,I3,1X,A3,1X,A1,I4,A1,3(1X,A4,2X),12X,F5.1) REMARK 500 REMARK 500 EXPECTED VALUES PROTEIN: ENGH AND HUBER, 1999 REMARK 500 EXPECTED VALUES NUCLEIC ACID: CLOWNEY ET AL 1996 REMARK 500 REMARK 500 M RES CSSEQI ATM1 ATM2 ATM3 REMARK 500 ARG A 41 CD - NE - CZ ANGL. DEV. = 9.0 DEGREES REMARK 500 ARG A 41 NE - CZ - NH2 ANGL. DEV. = -3.1 DEGREES REMARK 500 ILE A 50 CA - C - N ANGL. DEV. = 15.7 DEGREES REMARK 500 ARG A 57 CD - NE - CZ ANGL. DEV. = 10.5 DEGREES REMARK 500 ARG B 8 NE - CZ - NH1 ANGL. DEV. = 4.8 DEGREES REMARK 500 ARG B 57 NE - CZ - NH2 ANGL. DEV. = -4.7 DEGREES REMARK 500 REMARK 500 REMARK: NULL REMARK 620 REMARK 620 METAL COORDINATION REMARK 620 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 620 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE): REMARK 620 REMARK 620 COORDINATION ANGLES FOR: M RES CSSEQI METAL REMARK 620 NA A 501 NA REMARK 620 N RES CSSEQI ATOM REMARK 620 1 ASP A 60 O REMARK 620 2 HOH A 626 O 95.2 REMARK 620 3 HOH A 627 O 102.5 76.8 REMARK 620 4 HOH A 628 O 79.3 173.4 100.7 REMARK 620 5 HOH A 629 O 169.8 91.0 86.8 95.0 REMARK 620 6 HOH A 643 O 92.2 86.7 158.7 97.1 80.1 REMARK 620 N 1 2 3 4 5 REMARK 620 REMARK 620 COORDINATION ANGLES FOR: M RES CSSEQI METAL REMARK 620 NA B 202 NA REMARK 620 N RES CSSEQI ATOM REMARK 620 1 ASP B 60 O REMARK 620 2 HOH B1042 O 73.5 REMARK 620 3 HOH B1043 O 98.9 34.3 REMARK 620 4 HOH B1044 O 112.1 106.0 75.2 REMARK 620 5 HOH B1045 O 98.9 172.0 148.7 74.2 REMARK 620 6 HOH B1046 O 96.2 116.1 136.2 134.6 66.6 REMARK 620 N 1 2 3 4 5 REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE NA A 501 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE CL A 502 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC3 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE CL A 503 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC4 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE 0JV B 201 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC5 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE NA B 202 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC6 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE CL B 203 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC7 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE CL B 204 REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 2IEN RELATED DB: PDB REMARK 900 THE SAME PROTEIN COMPLEXED WITH DARUNAVIR REMARK 900 RELATED ID: 2Z4O RELATED DB: PDB REMARK 900 THE SAME PROTEIN COMPLEXED WITH GRL-98065 REMARK 900 RELATED ID: 2HB3 RELATED DB: PDB REMARK 900 THE SAME PROTEIN COMPLEXED WITH GRL-06579A REMARK 900 RELATED ID: 3DK1 RELATED DB: PDB REMARK 900 THE SAME PROTEIN COMPLEXED WITH GRL-0105A REMARK 900 RELATED ID: 3DJK RELATED DB: PDB REMARK 900 THE SAME PROTEIN COMPLEXED WITH GRL-0255A REMARK 900 RELATED ID: 3H5B RELATED DB: PDB REMARK 900 THE SAME PROTEIN COMPLEXED WITH GRL-02031 REMARK 900 RELATED ID: 3I6O RELATED DB: PDB REMARK 900 THE SAME PROTEIN COMPLEXED WITH GRL-0216A REMARK 900 RELATED ID: 3ST5 RELATED DB: PDB REMARK 900 THE SAME PROTEIN COMPLEXED WITH GRL-0489A REMARK 900 RELATED ID: 3OK9 RELATED DB: PDB REMARK 900 THE SAME PROTEIN COMPLEXED WITH GRL-0519A DBREF 4DFG A 1 99 UNP P03367 POL_HV1BR 501 599 DBREF 4DFG B 1 99 UNP P03367 POL_HV1BR 501 599 SEQADV 4DFG LYS A 7 UNP P03367 GLN 507 ENGINEERED MUTATION SEQADV 4DFG ILE A 33 UNP P03367 LEU 533 ENGINEERED MUTATION SEQADV 4DFG ILE A 63 UNP P03367 LEU 563 ENGINEERED MUTATION SEQADV 4DFG ALA A 67 UNP P03367 CYS 567 ENGINEERED MUTATION SEQADV 4DFG ALA A 95 UNP P03367 CYS 595 ENGINEERED MUTATION SEQADV 4DFG LYS B 7 UNP P03367 GLN 507 ENGINEERED MUTATION SEQADV 4DFG ILE B 33 UNP P03367 LEU 533 ENGINEERED MUTATION SEQADV 4DFG ILE B 63 UNP P03367 LEU 563 ENGINEERED MUTATION SEQADV 4DFG ALA B 67 UNP P03367 CYS 567 ENGINEERED MUTATION SEQADV 4DFG ALA B 95 UNP P03367 CYS 595 ENGINEERED MUTATION SEQRES 1 A 99 PRO GLN ILE THR LEU TRP LYS ARG PRO LEU VAL THR ILE SEQRES 2 A 99 LYS ILE GLY GLY GLN LEU LYS GLU ALA LEU LEU ASP THR SEQRES 3 A 99 GLY ALA ASP ASP THR VAL ILE GLU GLU MET SER LEU PRO SEQRES 4 A 99 GLY ARG TRP LYS PRO LYS MET ILE GLY GLY ILE GLY GLY SEQRES 5 A 99 PHE ILE LYS VAL ARG GLN TYR ASP GLN ILE ILE ILE GLU SEQRES 6 A 99 ILE ALA GLY HIS LYS ALA ILE GLY THR VAL LEU VAL GLY SEQRES 7 A 99 PRO THR PRO VAL ASN ILE ILE GLY ARG ASN LEU LEU THR SEQRES 8 A 99 GLN ILE GLY ALA THR LEU ASN PHE SEQRES 1 B 99 PRO GLN ILE THR LEU TRP LYS ARG PRO LEU VAL THR ILE SEQRES 2 B 99 LYS ILE GLY GLY GLN LEU LYS GLU ALA LEU LEU ASP THR SEQRES 3 B 99 GLY ALA ASP ASP THR VAL ILE GLU GLU MET SER LEU PRO SEQRES 4 B 99 GLY ARG TRP LYS PRO LYS MET ILE GLY GLY ILE GLY GLY SEQRES 5 B 99 PHE ILE LYS VAL ARG GLN TYR ASP GLN ILE ILE ILE GLU SEQRES 6 B 99 ILE ALA GLY HIS LYS ALA ILE GLY THR VAL LEU VAL GLY SEQRES 7 B 99 PRO THR PRO VAL ASN ILE ILE GLY ARG ASN LEU LEU THR SEQRES 8 B 99 GLN ILE GLY ALA THR LEU ASN PHE HET NA A 501 1 HET CL A 502 1 HET CL A 503 1 HET 0JV B 201 88 HET NA B 202 1 HET CL B 203 1 HET CL B 204 1 HETNAM NA SODIUM ION HETNAM CL CHLORIDE ION HETNAM 0JV METHYL N-[(3S,3AR,5R,6AR)-5-[[(2S,3R)-4-[(4- HETNAM 2 0JV METHOXYPHENYL)SULFONYL-(2-METHYLPROPYL)AMINO]-3- HETNAM 3 0JV OXIDANYL-1-PHENYL-BUTAN-2-YL]CARBAMOYLOXY]-3,3A,4,5,6, HETNAM 4 0JV 6A-HEXAHYDRO-2H-CYCLOPENTA[B]FURAN-3-YL]CARBAMATE FORMUL 3 NA 2(NA 1+) FORMUL 4 CL 4(CL 1-) FORMUL 6 0JV C31 H43 N3 O9 S FORMUL 10 HOH *228(H2 O) HELIX 1 1 GLY A 86 THR A 91 1 6 HELIX 2 2 GLN A 92 GLY A 94 5 3 HELIX 3 3 GLY B 86 THR B 91 1 6 SHEET 1 A 4 GLN A 2 THR A 4 0 SHEET 2 A 4 THR B 96 ASN B 98 -1 O LEU B 97 N ILE A 3 SHEET 3 A 4 THR A 96 ASN A 98 -1 N THR A 96 O ASN B 98 SHEET 4 A 4 GLN B 2 ILE B 3 -1 O ILE B 3 N LEU A 97 SHEET 1 B 8 TRP A 42 GLY A 49 0 SHEET 2 B 8 GLY A 52 ILE A 66 -1 O GLN A 58 N LYS A 43 SHEET 3 B 8 HIS A 69 VAL A 77 -1 O HIS A 69 N ILE A 66 SHEET 4 B 8 VAL A 32 ILE A 33 1 N ILE A 33 O LEU A 76 SHEET 5 B 8 ILE A 84 ILE A 85 -1 O ILE A 84 N VAL A 32 SHEET 6 B 8 GLN A 18 LEU A 24 1 N LEU A 23 O ILE A 85 SHEET 7 B 8 LEU A 10 ILE A 15 -1 N ILE A 13 O LYS A 20 SHEET 8 B 8 GLY A 52 ILE A 66 -1 O GLU A 65 N LYS A 14 SHEET 1 C 8 LYS B 43 GLY B 49 0 SHEET 2 C 8 GLY B 52 ILE B 66 -1 O GLN B 58 N LYS B 43 SHEET 3 C 8 HIS B 69 VAL B 77 -1 O ALA B 71 N ILE B 64 SHEET 4 C 8 VAL B 32 ILE B 33 1 N ILE B 33 O LEU B 76 SHEET 5 C 8 ILE B 84 ILE B 85 -1 O ILE B 84 N VAL B 32 SHEET 6 C 8 GLN B 18 LEU B 24 1 N LEU B 23 O ILE B 85 SHEET 7 C 8 LEU B 10 ILE B 15 -1 N ILE B 13 O LYS B 20 SHEET 8 C 8 GLY B 52 ILE B 66 -1 O GLU B 65 N LYS B 14 LINK O ASP A 60 NA NA A 501 1555 1555 2.38 LINK NA NA A 501 O HOH A 626 1555 1555 2.38 LINK NA NA A 501 O HOH A 627 1555 1555 2.27 LINK NA NA A 501 O HOH A 628 1555 1555 2.36 LINK NA NA A 501 O HOH A 629 1555 1555 2.76 LINK NA NA A 501 O HOH A 643 1555 1555 2.40 LINK O ASP B 60 NA NA B 202 1555 1555 2.44 LINK NA NA B 202 O HOH B1042 1555 1555 2.31 LINK NA NA B 202 O HOH B1043 1555 1555 2.93 LINK NA NA B 202 O HOH B1044 1555 1555 2.28 LINK NA NA B 202 O HOH B1045 1555 1555 2.63 LINK NA NA B 202 O HOH B1046 1555 1555 2.50 SITE 1 AC1 6 ASP A 60 HOH A 626 HOH A 627 HOH A 628 SITE 2 AC1 6 HOH A 629 HOH A 643 SITE 1 AC2 4 THR A 74 ASN A 88 HOH A 632 ARG B 41 SITE 1 AC3 2 LYS A 7 ARG A 8 SITE 1 AC4 35 ARG A 8 ASP A 25 GLY A 27 ALA A 28 SITE 2 AC4 35 ASP A 29 ASP A 30 GLY A 48 GLY A 49 SITE 3 AC4 35 ILE A 50 PRO A 81 VAL A 82 ILE A 84 SITE 4 AC4 35 HOH A 652 ARG B 8 ASP B 25 GLY B 27 SITE 5 AC4 35 ALA B 28 ASP B 29 ASP B 30 ILE B 47 SITE 6 AC4 35 GLY B 48 GLY B 49 ILE B 50 PRO B 81 SITE 7 AC4 35 VAL B 82 ILE B 84 HOH B1001 HOH B1031 SITE 8 AC4 35 HOH B1073 HOH B1074 HOH B1076 HOH B1096 SITE 9 AC4 35 HOH B1098 HOH B1099 HOH B1101 SITE 1 AC5 6 ASP B 60 HOH B1042 HOH B1043 HOH B1044 SITE 2 AC5 6 HOH B1045 HOH B1046 SITE 1 AC6 3 THR B 74 ASN B 88 HOH B1008 SITE 1 AC7 1 TRP B 6 CRYST1 58.580 85.930 45.990 90.00 90.00 90.00 P 21 21 2 8 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.017071 0.000000 0.000000 0.00000 SCALE2 0.000000 0.011637 0.000000 0.00000 SCALE3 0.000000 0.000000 0.021744 0.00000